OneLAX SENNA SYRUP

Manufacturer: Atlantic Biologicals Corp.
Effective date: 2025-10-01
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 01:15:35

Label at a glance#

ProductOneLAX SENNA

Active ingredientSENNOSIDES A AND B

Label structure9 sections

Indications and uses

relieves occasional constipation (irregularity), generally causes bowel movement in 6 to 12 hours

Dosage and administration

take preferably at bedtime or as directed by a doctor. Shake Well Before Using.

Storage and handling

Avoid accessive heat. Store at room temperature 15°-30°C (59°-86°F)

Contacts and useful links#

PhonePoison Help1(800) 222-1222

PhoneLabel contact1(800) 509-7592

Websitewww.fda.gov

www.fda.gov/medwatch

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active ingredient(in each teaspoonful) Purpose
Sennosides 8.8 mg …………………………................Laxative

Uses

OTC - PURPOSE SECTION

relieves occasional constipation (irregularity), generally causes bowel movement in 6 to 12 hours

Warnings

WARNINGS SECTION

ask a doctor before use if you have • stomach pain • nausea • vomiting • noticed a sudden change in bowel movements that continues over a period of 2 weeks

Do not use laxative products for longer than 1 week unless directed by a doctor

Ask a doctor or pharmacist before use if

OTC - ASK DOCTOR SECTION

you are taking any other drug. Take this product two more hours before or after other drugs. Laxatives may affect how other drugs work.

Stop use and ask a doctor if

OTC - STOP USE SECTION

you have rectal bleeding or fail to have bowel movement after use of laxative. This may indicate a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

INDICATIONS & USAGE SECTION

take preferably at bedtime or as directed by a doctor. Shake Well Before Using.

DOSAGE & ADMINISTRATION SECTION


age	starting dose	maximum dosage
Adults and children 12 yeart and older	2-3 teaspoons once a day	3 teaspoons twice a day
Children 6 years to under 12 yeart	1 - 1 ^1/2teaspoons once a day	1 ^1/2teaspoons twice a day
Children 2 years to under 6 yeart	^l/2- ^3/4teaspoon once a day	3/4 teaspoon twice a day
Children under 2 years	ask a doctor	ask a doctor

Other Information

STORAGE AND HANDLING SECTION

Avoid accessive heat. Store at room temperature 15°-30°C (59°-86°F)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

flavor choclate, mythylparaben, propylene glycol, propylparaben, purified water and sucrose

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental overdose, get medical help immediately or contact Poison Control Center immediately 1(800) 222-1222

To Report Adverse Drug Event contact the FDA at 1-800- FDA-1088 or www.fda.gov/medwatch.

Questions?

Call 1(800) 509-7592

Distributed By:

Atlaantic Biologicals Corp.

Miami, FL 33179

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
702311	sennosides 8.8 MG in 5 mL Oral Solution	PSN	1
702311	sennosides, USP 1.76 MG/ML Oral Solution	SCD	1
702311	sennosides 8.8 MG per 5 mL Oral Syrup	SY	1
702311	sennosides, USP 26.4 MG per 15 ML Oral Solution	SY	1
702311	sennosides, USP 8.8 MG per 5 ML Oral Solution	SY	1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17856-8127-2	OneLAX SENNA	50 in 1 CASE	SYRUP	50		1
17856-8127-2	OneLAX SENNA	5 mL in 1 CUP, UNIT-DOSE	SYRUP	5		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
71399-0027-8	ML - Milliliter	71399-0027	fe9b506a-3920-4704-9b2c-1015086984ee	1	2024-03-12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

OneLAX SENNA
SENNA
METHYLPARABEN
PROPYLENE GLYCOL
PROPYLPARABEN
WATER
SUCROSE
SENNOSIDES A AND B

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17856-8127	17856-8127-2
71399-0027

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
METHYLPARABEN	A2I8C7HI9T	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
WATER	059QF0KO0R	IACT
SUCROSE	C151H8M554	IACT
SENNOSIDES A AND B	1B5FPI42EN	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OneLAX SENNA	SENNA	Akron Pharma Inc.	27fa8f54-ed84-4afd-8da3-8754da48643b	2026-09-01	Warnings	Exact identifier ndc (product): 71399-0027
OneLAX SENNA	SENNA	Atlantic Biologicals Corp.	40202c76-4273-88fd-e063-6394a90a07b2	2025-10-01	Warnings	Exact identifier ndc (package): 17856-8127-2 ndc (product): 17856-8127 ndc11 (package): 17856812702 spl id: 40202c81-a84f-63e9-e063-6294a90a8947 spl set id: 40202c76-4273-88fd-e063-6394a90a07b2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.